These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30634752)

  • 21. [Update Knowledge for Brain Tumors(3)Astrocytic Tumors].
    Nagane M
    No Shinkei Geka; 2016 Jan; 44(1):71-89. PubMed ID: 26771099
    [No Abstract]   [Full Text] [Related]  

  • 22. The progression in astrocytic tumors.
    Roselli R; Iacoangeli M; Carapella CM; Scerrati M
    J Neurosurg Sci; 1990; 34(3-4):199-204. PubMed ID: 2098497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors.
    Saito T; Yamasaki F; Kajiwara Y; Abe N; Akiyama Y; Kakuda T; Takeshima Y; Sugiyama K; Okada Y; Kurisu K
    Eur J Radiol; 2012 Aug; 81(8):1863-9. PubMed ID: 21543173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measurement of PCNA labeling index in astrocytic tumors].
    Beppu T; Arai H; Kanaya H; Sasaki K
    No Shinkei Geka; 1992 Dec; 20(12):1255-9. PubMed ID: 1362456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors.
    Kim NK; Ahn JY; Song J; Kim JK; Han JH; An HJ; Chung HM; Joo JY; Choi JU; Lee KS; Roy R; Oh D
    Anticancer Res; 2003; 23(2B):1417-23. PubMed ID: 12820404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristics of hemispheric astrocytic tumors at an early age].
    Zapata JE
    Rev Clin Esp; 1971 Jul; 122(6):5-12. PubMed ID: 4330402
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.
    Yoon HJ; Ahn KJ; Lee S; Jang JH; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
    Neuroradiology; 2017 Jul; 59(7):665-675. PubMed ID: 28550465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of Cx43 in astrocytic tumors.
    Pu P; Xia Z; Yu S; Huang Q
    Clin Neurol Neurosurg; 2004 Dec; 107(1):49-54. PubMed ID: 15567553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral astrocytic neoplasms in the adult: contribution of histologic examination to the assessment of prognosis.
    Fulling KH; Nelson JS
    Semin Diagn Pathol; 1984 May; 1(2):152-63. PubMed ID: 6100972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant astrocytoma as a recurrance of astrocytoma II WHO after 13 years. Case report and literature review].
    Parafiniuk D; Jezewski D; Nowacki P
    Ann Acad Med Stetin; 2010; 56(2):45-50. PubMed ID: 21473001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade.
    Tan G; Sun SQ; Yuan DL
    Biochem Biophys Res Commun; 2008 Mar; 367(4):743-7. PubMed ID: 18191638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical pattern of P53 protein in human astrocytic tumors.
    Howng SL; Hwang SL; Chai CY; Lin HJ
    Kaohsiung J Med Sci; 1996 May; 12(5):279-84. PubMed ID: 8676433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ultrastructure of glial tumors of astrocytic lineage: a review.
    Liberski PP
    Folia Neuropathol; 1998; 36(3):161-77. PubMed ID: 9833393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
    Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.
    Cai J; Chen J; Zhang W; Yang P; Zhang C; Li M; Yao K; Wang H; Li Q; Jiang C; Jiang T
    Oncotarget; 2015 Jul; 6(20):18105-15. PubMed ID: 25971279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocytic tumors.
    Riemenschneider MJ; Reifenberger G
    Recent Results Cancer Res; 2009; 171():3-24. PubMed ID: 19322535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Astrocytoma of the frontal parietal].
    CAETANO DA SILVA JUNIOR JA; TENUTO R
    Arq Neuropsiquiatr; 1947; 5(3):295-8. PubMed ID: 18904493
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes of the bromodeoxyuridine labeling index of astrocytic tumors between primary and recurrent lesions.
    Tamura M; Ono N; Zama A; Kurihara H
    Noshuyo Byori; 1994; 11(2):173-6. PubMed ID: 7894621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.